Status:
COMPLETED
Narrative Medicine and Pediatric Oncology
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Pediatric Residents Rotating in Pediatric Oncology
Eligibility:
All Genders
Phase:
NA
Brief Summary
The investigators' objective is to implement an innovative curriculum in narrative medicine for pediatric residents rotating at Memorial Sloan Kettering Cancer Center (MSKCC), and to evaluate whether ...
Detailed Description
Methods and Procedures This study is designed to evaluate the impact of a narrative medicine curriculum on a convenience sample of pediatric residents rotating through MSKCC during the 2020-2021 acade...
Eligibility Criteria
Inclusion
- Pediatric residents
- Rotating through Memorial Sloan Kettering Cancer Center during the 2020-2021 academic year
- Who complete at least 2 sessions in narrative medicine, including the pre-test and post-test.
Exclusion
- Residents who are on an elective rotation, rather than a compulsory rotation,
- Residents who have already rotated once through MSKCC during the Jan 2020-Jan 2021 calendar year if their first rotation was an intervention block.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04489316
Start Date
July 1 2020
End Date
July 1 2021
Last Update
September 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065